Rho-Associated Kinases in Tumorigenesis: Re-Considering ROCK Inhibition for Cancer Therapy

EMBO Reports - United States
doi 10.1038/embor.2012.127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EMBO

Related search

Apoptosis in Tumorigenesis and Cancer Therapy

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
1997English

Inhibiting Cell Cycle Kinases in Cancer Therapy

2012English

Rho Kinases in Cardiovascular Physiology and Pathophysiology

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2013English

Thrombin Drives Tumorigenesis in Colitis-Associated Colon Cancer

Cancer Research
Cancer ResearchOncology
2014English

Complement Inhibition in Cancer Therapy

Seminars in Immunology
AllergyImmunology
2013English

Screening for Functional Kinases in Metastatic Prostate Cancer: A Glimmer of Hope for Kinase Inhibition

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Inhibition of Ciliogenesis Promotes Hedgehog Signaling, Tumorigenesis, and Metastasis in Breast Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Inhibition of Mxi1 Suppresses HIF-2α-dependent Renal Cancer Tumorigenesis

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Peptide Substrates for Rho-Associated Kinase 2 (Rho-Kinase 2/Rock2)

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy